Skip to main content
Premium Trial:

Request an Annual Quote

MDS Extends Offer to Buy Molecular Devices to Meet Foreign Regulations

NEW YORK (GenomeWeb News) – MDS has extended to March 19 its offer to buy Molecular Devices in order to give it additional time to meet “certain foreign regulatory conditions,” MDS said today.

The company still expects the deal to close within the next few weeks. It is in the process of meeting regulatory requirements in and in , MDS spokesperson Catherine Melville told GenomeWeb News.  

As GenomeWeb News previously in January, the companies had agreed to a deal under which MDS would buy Molecular Devices for $615 million in cash, or $35.50 a share for all of Molecular Devices’ common stock.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.